Good bugs and bad bugs: Indications and therapies for Helicobacter pylori eradication

Current Opinion in Pharmacology

Volumn 3, Issue 5, 2003, Pages 480-485

  Kuipers, Ernst J ^a   Janssen, Marcel J R ^b   de Boer, Wink A ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BERNHOVEN HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BISMUTH; CISAPRIDE; CLARITHROMYCIN; HELICOBACTER PYLORI VACCINE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; CANCER PREVENTION; CANCER SURGERY; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM ULCER; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; STANDARD; STOMACH CANCER; TREATMENT INDICATION; TREATMENT PLANNING; UPPER GASTROINTESTINAL TRACT;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DYSPEPSIA; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PROTON PUMPS; STOMACH NEOPLASMS;

EID: 0141535262     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(03)00116-4     Document Type: Review

References (50)

1. Kuipers E.J. Israel D.A. Kusters J.G. Gerrits M.M. Weel J. van der Ende A. van der Hulst R.W.M. Wirth H.P. Höök-Nikanne J. Thompson S.A. et al. Quasispecies development in Helicobacter pylori observed in paired isolates obtained years apart in the same host J Infect Dis 181 2000 273-282
2. Israel D.A. Salama N. Krishna U. Rieger U.M. Atherton J.C. Falkow S. Peek R.M. Helicobacter pylori genetic diversity within the gastric niche of a single human host Proc Natl Acad Sci USA 98 2001 14625-14630
3. Falush D. Wirth T. Linz B. Pritchard J.K. Stephens M. Kidd M. Blaser M.J. Graham D.Y. Vacher S. Perez-Perez G.I. et al.Traces of human migrations in Helicobacter pylori populations Science 299 2003 1582-1585
4. Ghose C. Perez-Perez G.I. Dominguez-Bello M.G. Pride D.T. Bravi C.M. Blaser M.J. East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage Proc Natl Acad Sci USA 99 2002 15107-15111
5. Odenbreit S. Puls J. Sedlmaier B. Gerland E. Fischer W. Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion Science 287 2000 1497-1500
6. Guillemin K. Salama N.R. Tompkins L.S. Falkow S. Cag-pathogenicity-island-specific responses of gastric epithelial cells to Helicobacter pylori infection Proc Natl Acad Sci USA 99 2002 15136-15141
7. McColl K.E.L. Murray L. El-Omar E. Dickson A. El-Nujumi A. Wirz A. Kelman A. Penny C. Knill-Jones R. Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in nonulcer dyspepsia N Engl J Med 339 1998 1869-1874
8. Blum A.L. Talley N.J. O'Morain C. Veldhuyzen van Zanten S. Labenz J. Stolte M. Louw J.A. Stubberöd A. Theodórs A. Sundin M. et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia N Engl J Med 339 1998 1875-1881
9. Talley N.J. Janssens J. Lauritsen K. Racz J. Bolling-Sternevald E. Long-term follow-up of patients with non-ulcer dyspepsia after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial Br Med J 318 1999 833-837
10. Talley N.J. Vakil N. Ballard E.D. Fennerty M.B. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia N Engl J Med 341 1999 1106-1111
11. Greenberg P.D. Cello J.P. Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia Arch Intern Med 159 1999 2283-2288
12. McNamara D. Buckley M. Gilvarry J. O'Morain C. Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a five-year follow-up study Helicobacter 7 2002 317-321
13. Laine L. Schoenfeld P. Fennerty M.B. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials Ann Intern Med 134 2001 361-369
14. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003, CD002096.
15. Chiba N. Veldhuyzen van Zanten S.J. Sinclair P. Ferguson R.A. Escobedo S. Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - Helicobacter positive (CADET-Hp) randomized controlled trial Br Med J 324 2002 1012-1016
16. Arents N.L.A. Thijs J.C. van Zwet A.A. Oudkerk Pool M. Götz J.-M. van de Werf G.T. Reenders K. Sluiter W.J. Kleibeuker J.H. The approach of dyspepsia in primary care. A randomized trial comparing 'test and treat' with prompt endoscopy Arch Intern Med 163 2003 1606-1612
17. Kuipers E.J. Helicobacter pylori infection and the risk and management of associated disorders: gastritis, ulcer disease, atrophic gastritis and gastric cancer Aliment Pharmacol Ther 11 1997 71-88
18. Leodolter A. Kulig M. Brasch H. Meyer-Sabellek W. Willich S.N. Malfertheiner P. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer Aliment Pharmacol Ther 15 2001 1949-1958
19. Brock J. Sauaia A. Ahnen D. Marine W. Schluter W. Stevens B.R. Scinto J.D. Karp H. Bratzler D. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease J Am Med Assoc 286 2001 1985-1993
20. Hurenkamp G.J. Grundmeijer H.G. van der Ende A. Tytgat G.N.J. Assendelft W.J. van der Hulst R.W. Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study Aliment Pharmacol Ther 15 2001 1047-1054
21. Vreeburg E.M. Snel P. de Bruijne H.W. Bartelsman J.F.W.M. Rauws E.A.J. Tytgat G.N.J. Acute upper gastrointestinal bleeding in the Amsterdam area; incidence, diagnosis and clinical outcome Am J Gastroenterol 92 1997 236-243
22. Huang J.Q. Sridhar S. Hunt R.H. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis Lancet 359 2002 14-22
23. Hawkey C.J. Karrasch J.A. Szczepanski L. Walker D.G. Barkun A. Swannell A.J. Yeomans N.D. Omeprazole compared with misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs. Omeprazole versus misoprostol for NSAID-induced ulcer management (OMNIUM) study group N Engl J Med 338 1998 727-734
24. Feldman M. Cryer B. Mallat D. Go M.F. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial Am J Gastroenterol 96 2001 1751-1757
25. Chan F.K.L. To K.F. Wu J.C.Y. Leung W.K. Kwok T. Hui Y. Chan H.L.Y. Chan C.S.Y. Hui E. Woo J. et al. Eradication of Helicobacter pylori and the risk of peptic ulcers in patients starting on long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial Lancet 359 2002 9-13
26. Chan F.K.L. Sung J.Y. Suen R. Lee Y.T. Leung W.K. Leung V.K. Wu J.C. Lau J.Y. Hui Y. Lai M.S. et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 2001 967-973
27. Werdmuller B.F.M. Loffeld R.J.L.F. Helicobacter pylori has no role in the pathogenesis of reflux esophagitis Dig Dis Sci 42 1997 103-105
28. Labenz J. Blum A.L. Bayerdörffer E. Meining A. Stolte M. Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis Gastroenterology 112 1997 1442-1447
29. Laine L. Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double-blind prospective studies Am J Gastroenterol 97 2002 2992-2997
30. Kuipers E.J. Lundell L. Klinkenberg-Knol E.C. Havu N. Festen H.P.M. Liedman B. Lamers C.B.H.W. Jansen J.B.M.J. Dalenbäck J. Snel P. et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication N Engl J Med 334 1996 1018-1022
31. Malfertheiner P. Megraud F. O'Morain C. Hungin A.P. Jones R. Axon A. Graham D.Y. Tytgat G. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 consensus report Aliment Pharmacol Ther 16 2002 167-180
32. Schenk B.E. Kuipers E.J. Klinkenberg-Knol E.C. Eskes S.A. Meuwissen S.G.M. Helicobacter pylori and the efficacy of omeprazole for gastroesophageal reflux disease Am J Gastroenterol 94 1999 884-887
33. Moayyedi P. Bardhan C. Young L. Dixon M.F. Brown L. Axon A.T. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastro-esophageal reflux disease Gastroenterology 121 2001 1120-1126
34. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HPM, Dent J, Zeitoun P, Havu N et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long-term omeprazole reverses gastritis without exacerbation of reflux disease; results of a randomised controlled trial. Gut 2003, in press.
35. International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 61, Schistosomes, Liver Flukes and Helicobacter pylori. Lyon; 1994.
36. Uemura N. Okamoto S. Yamamoto S. Mutsumura N. Yamaguchi S. Yamakido M. Taniyama K. Sasaki N. Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 2001 784-789
37. Uemura N. Mukai T. Okamoto S. Yamaguchi S. Mashiba H. Taniyama K. Sasaki N. Haruma K. Sumii K. Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomark Prev 6 1997 639-642
38. Sung J.J. Lin S.R. Ching J.Y. Zhou L.Y. To K.F. Wang R.T. Leung W.K. Ng E.K. Lau J.Y. Lee Y.T. et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study Gastroenterology 119 2000 7-14
39. Wong B.C.Y. Lam S.K. Wong W.M. Zheng T. Chen J. Chen B. Lai K. Yuen S. Ho J. Eradicating Helicobacter pylori infection in general population prevents gastric cancer: a seven-year prospective randomized placebo-controlled study Gastroenterology 122 2002 A588-A589
40. Parsonnet J. Harris R.A. Hack H.M. Owens D.K. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Lancet 348 1996 150-154
41. Roderick P. Davies R. Raftery J. Crabbe D. Pearce R. Bhandari P. Patel P. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model Health Technol Assess 7 2003 1-86
42. Vallve M. Vergara M. Gisbert J.P. Calvet X. Single vs. double dose of a proton-pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis Aliment Pharmacol Ther 16 2002 1149-1156
43. Calvet X. Gene E. Lopez T. Gisbert J.P. What is the optimal length of proton-pump-inhibitor-based triple therapies for Helicobacter pylori? A cost-effectiveness analysis Aliment Pharmacol Ther 15 2001 1067-1076
44. Laine L. Hunt R. El Zimaity H.M. Nguyen B. Osato M. Spenard J. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized multicenter, North American trial Am J Gastroenterol 98 2003 562-567
45. Katelaris P.H. Forbes G.M. Talley N.J. Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the Quadrate study Gastroenterology 123 2002 1763-1769
46. O'Morain C. Borody T. Farley A. de Boer W.A. Dallaire C. Schuman R. Piotrowski J. Fallone C.A. Tytgat G. Megraud F. et al. Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study Aliment Pharmacol Ther 17 2003 415-420
47. Cats A. Kuipers E.J. Bosschaert M.A.R. Pot R.J.G. Sako T. Vandenbroucke-Grauls C.M.J.E. Kusters J.G. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects Aliment Pharmacol Ther 17 2003 429-435
48. Angelakopoulos H. Hohmann E.L. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers Infect Immun 68 2000 2135-2141
49. Banerjee S. Medina-Fatimi A. Nichols R. Tendler D. Michetti M. Simon J. Kelly C.P. Monath T.P. Michetti P. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers Gut 51 2002 634-640
50. Rupnow M.F. Shachter R.D. Owens D.K. Parsonnet J. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine Vaccine 12 2001 879-885